Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “G-CSF”

635 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 635 results

Testing effectiveness (Phase 2)Study completedNCT03531918
What this trial is testing

Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm

Who this might be right for
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center 66
Large-scale testing (Phase 3)Study completedNCT01079676
What this trial is testing

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Who this might be right for
Neutropenia in Breast Cancer
Eurofarma Laboratorios S.A. 220
Early research (Phase 1)Study completedNCT02703051
What this trial is testing

Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects

Who this might be right for
Healthy Volunteers
GlycoMimetics Incorporated 54
Testing effectiveness (Phase 2)Study completedNCT00506857
What this trial is testing

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 82
Large-scale testing (Phase 3)Ended earlyNCT00016341
What this trial is testing

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)UnknownNCT00030719
What this trial is testing

Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
University of Leicester 175
Testing effectiveness (Phase 2)UnknownNCT02027220
What this trial is testing

Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma

Who this might be right for
MyelomaBortezomibCyclophosphamide+2 more
Second Affiliated Hospital of Soochow University 60
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Early research (Phase 1)Study completedNCT02762799
What this trial is testing

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Who this might be right for
Leucocytosis
Biocad 60
Large-scale testing (Phase 3)Study completedNCT00776165
What this trial is testing

Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)

Who this might be right for
Chemotherapy-Induced Neutropenia
Shantha Biotechnics Limited 126
Early research (Phase 1)Study completedNCT03263936
What this trial is testing

Epigenetic Reprogramming in Relapse/Refractory AML

Who this might be right for
Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 37
Early research (Phase 1)Study completedNCT03246009
What this trial is testing

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

Who this might be right for
Chemotherapy-induced NeutropeniaCancer, Breast
Tianjin SinoBiotech Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00135928
What this trial is testing

Stem Cells in Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Rigshospitalet, Denmark 78
Large-scale testing (Phase 3)Study completedNCT00837265
What this trial is testing

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

Who this might be right for
Chemotherapy-induced Neutropenia
Teva Branded Pharmaceutical Products R&D, Inc. 334
Testing effectiveness (Phase 2)Study completedNCT01302171
What this trial is testing

Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy

Who this might be right for
Dilated Cardiomyopathy
Barts & The London NHS Trust 60
Early research (Phase 1)Study completedNCT01057264
What this trial is testing

HAI Abraxane With Gemcitabine and Bevacizumab

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT00554463
What this trial is testing

G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 5
Testing effectiveness (Phase 2)Study completedNCT00483067
What this trial is testing

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 13
Post-approval studies (Phase 4)UnknownNCT00199147
What this trial is testing

Efficacy of G-CSF-Priming in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
Johann Wolfgang Goethe University Hospital 250
Large-scale testing (Phase 3)Ended earlyNCT03029000
What this trial is testing

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

Who this might be right for
Healthy Participants
Teva Branded Pharmaceutical Products R&D, Inc. 1
Load More Results